27
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Candidemia Before and During the Fluconazole Era: Prevalence, Type of Species and Approach to Treatment in a Tertiary Care Community Hospital

Pages 137-139 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Liv Hesstvedt, Peter Gaustad, Fredrik Müller, Cecilie Torp Andersen, Cathrine Brunborg, Haima Mylvaganam, Rafael Alexander Leiva, Jan Erik Berdal, Trond Egil Ranheim, Bjørn Odd Johnsen, Birgit M. Falch, Gro Grimnes, Vegard Skogen, Elisebet Haarr, Anita Sandmo Lyngøy, Kjersti Wik Larssen, Raisa Hannula, Bjørn Åsheim Hansen & Ingvild Nordøy. (2019) The impact of age on risk assessment, therapeutic practice and outcome in candidemia. Infectious Diseases 51:6, pages 425-434.
Read now
Maria Elisa Rodrigues, Sónia Silva, Joana Azeredo & Mariana Henriques. (2016) Novel strategies to fight Candida species infection. Critical Reviews in Microbiology 42:4, pages 594-606.
Read now
Michael A. Pfaller & Daniel J. Diekema. (2010) Epidemiology of Invasive Mycoses in North America. Critical Reviews in Microbiology 36:1, pages 1-53.
Read now
Stefan Langner, Philipp B Staber & Peter Neumeister. (2008) Posaconazole in the management of refractory invasive fungal infections. Therapeutics and Clinical Risk Management 4:4, pages 747-758.
Read now
Alicia Gómez-López, Oscar Zaragoza, Juan Luis Rodríguez-Tudela & Manuel Cuenca-Estrella. (2008) Pharmacotherapy of yeast infections. Expert Opinion on Pharmacotherapy 9:16, pages 2801-2816.
Read now
Joshua Perlroth, Bryan Choi & Brad Spellberg. (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Medical Mycology 45:4, pages 321-346.
Read now

Articles from other publishers (48)

Ben Y. Parslow & Christopher R. Thornton. (2022) Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis. Microorganisms 10:6, pages 1208.
Crossref
Jonathan Spahr, Daniel J. Weiner, Dennis C. Stokes & Geoffrey Kurland. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children 923 943.e7 .
Liv Hesstvedt, Maiken C. Arendrup, Eira Poikonen, Lena Klingpor, Vanda Friman & Ingvild Nordøy. (2016) Differences in epidemiology of candidaemia in the Nordic countries – what is to blame?. Mycoses 60:1, pages 11-19.
Crossref
Riad Khatib, Leonard B. Johnson, Mohamad G. Fakih, Kathleen Riederer & Laurence Briski. (2016) Current trends in candidemia and species distribution among adults: Candida glabrata surpasses C. albicans in diabetic patients and abdominal sources . Mycoses 59:12, pages 781-786.
Crossref
Marya Zilberberg, Hsing-Ting Yu, Paresh Chaudhari, Matthew F Emons, Nikhil Khandelwal & Andrew F Shorr. (2014) Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Critical Care 18:5.
Crossref
Katsumi Shigemura, Kayo Osawa, Takumi Jikimoto, Hiroyuki Yoshida, Brian Hayama, Goh Ohji, Kentaro Iwata, Masato Fujisawa & Soichi Arakawa. (2014) Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection. The Journal of Antibiotics 67:4, pages 311-314.
Crossref
Lucas Ruiz Storti, Giuliano Pasquale, Rogério Scomparim, Ana Lúcia Galastri, Flávio Alterthum, Walderez Gambale & Claudete Rodrigues Paula. (2012) Candida spp. isolated from inpatients, the environment, and health practitioners in the pediatric unit at the Universitary Hospital of the Jundiaí Medical College, state of São Paulo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 45:2, pages 225-231.
Crossref
Jonathan. Spahr, Daniel J. Weiner, Dennis C. Stokes & Geoffrey. Kurland. 2012. Kendig & Chernickâs Disorders of the Respiratory Tract in Children. Kendig & Chernickâs Disorders of the Respiratory Tract in Children 899 919 .
Michael A. Pfaller & Daniel J. Diekema. 2011. Candida and Candidiasis . Candida and Candidiasis 449 480 .
Russell E. Lewis & Dimitrios P. Kontoyiannis. 2011. Candida and Candidiasis . Candida and Candidiasis 373 385 .
Matthew E. Falagas, Nikos Roussos & Konstantinos Z. Vardakas. (2010) Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. International Journal of Infectious Diseases 14:11, pages e954-e966.
Crossref
Rana Traboulsi. 2009. Antifungal Therapy. Antifungal Therapy 278 292 .
Benoite Kaeser, Hagen Zandt, Fabrice Bour, Elke Zwanziger, Christophe Schmitt & Xiaoping Zhang. (2009) Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir. Antimicrobial Agents and Chemotherapy 53:2, pages 609-614.
Crossref
Maria-Cecilia Dignani, Joseph S. Solomkin & Elias J. Anaissie. 2009. Clinical Mycology. Clinical Mycology 197 229 .
David Trofa, Attila Gácser & Joshua D. Nosanchuk. (2008) Candida parapsilosis , an Emerging Fungal Pathogen . Clinical Microbiology Reviews 21:4, pages 606-625.
Crossref
Jennifer K. Chow, Yoav Golan, Robin Ruthazer, Adolf W. Karchmer, Yehuda Carmeli, Deborah A. Lichtenberg, Varun Chawla, Janet A. Young & Susan Hadley. (2008) Risk factors for albicans and non-albicans candidemia in the intensive care unit*. Critical Care Medicine 36:7, pages 1993-1998.
Crossref
Jennifer K. Chow, Yoav Golan, Robin Ruthazer, Adolf W. Karchmer, Yehuda Carmeli, Deborah Lichtenberg, Varun Chawla, Janet Young & Susan Hadley. (2008) Factors Associated with Candidemia Caused by Non‐ albicans Candida Species Versus Candida albicans in the Intensive Care Unit . Clinical Infectious Diseases 46:8, pages 1206-1213.
Crossref
George Dimopoulos, Fotinie Ntziora, George Rachiotis, Apostolos Armaganidis & Matthew E. Falagas. (2008) Candida Albicans Versus Non-Albicans Intensive Care Unit-Acquired Bloodstream Infections: Differences in Risk Factors and Outcome. Anesthesia & Analgesia 106:2, pages 523-529.
Crossref
Z. A. Kanafani & J. R. Perfect. (2008) Resistance to Antifungal Agents: Mechanisms and Clinical Impact. Clinical Infectious Diseases 46:1, pages 120-128.
Crossref
Chih-Cheng Lai, Che-Kim Tan, Yu-Tsung Huang, Pei-Lan Shao & Po-Ren Hsueh. (2008) Current challenges in the management of invasive fungal infections. Journal of Infection and Chemotherapy 14:2, pages 77-85.
Crossref
Beth A. Arthington-Skaggs & John H. Rex. 2008. Antimicrobial Resistance and Implications for the Twenty-First Century. Antimicrobial Resistance and Implications for the Twenty-First Century 325 369 .
Ricard Jordà‐Marcos, Francisco Álvarez‐Lerma, Maite Jurado, Mercedes Palomar, Juan Nolla‐Salas, María A. León & Cristóbal León. (2007) Risk factors for candidaemia in critically ill patients: a prospective surveillance study*. Mycoses 50:4, pages 302-310.
Crossref
Christopher C. Blyth, Pamela Palasanthiran & Tracey A. O'Brien. (2007) Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review. Pediatrics 119:4, pages 772-784.
Crossref
Peter H. Michelson, Rakesh Goyal & Geoffrey Kurland. (2007) Pulmonary complications of haematopoietic cell transplantation in children. Paediatric Respiratory Reviews 8:1, pages 46-61.
Crossref
M. A. Pfaller & D. J. Diekema. (2007) Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clinical Microbiology Reviews 20:1, pages 133-163.
Crossref
Peter G. Pappas. (2006) Invasive Candidiasis. Infectious Disease Clinics of North America 20:3, pages 485-506.
Crossref
Michael A. Pfaller, Peter G. Pappas & John R. Wingard. (2006) Invasive Fungal Pathogens: Current Epidemiological Trends. Clinical Infectious Diseases 43:Supplement_1, pages S3-S14.
Crossref
Carlos I Bustamante. (2005) Treatment of Candida infection: a view from the trenches!. Current Opinion in Infectious Diseases 18:6, pages 490-495.
Crossref
Brad J. Spellberg, Ashraf S. Ibrahim, Valentina Avenissian, Scott G. Filler, Carter L. Myers, Yue Fu & John E. EdwardsJr.Jr.. (2005) The Anti- Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice . Infection and Immunity 73:9, pages 6191-6193.
Crossref
Lucía García San Miguel, Javier Cobo, Enrique Otheo, Aurora Sánchez-Sousa, Victor Abraira & Santiago Moreno. (2016) Secular Trends of Candidemia in a Large Tertiary-Care Hospital From 1988 to 2000: Emergence of Candida parapsilosis . Infection Control & Hospital Epidemiology 26:6, pages 548-552.
Crossref
Mark J. DiNubile, Darcy Hille, Carole A. Sable & Nicholas A. Kartsonis. (2005) Invasive candidiasis in cancer patients: observations from a randomized clinical trial. Journal of Infection 50:5, pages 443-449.
Crossref
H. Agırbaslı, S. A. Keceli Özcan & Gündüz Gedikoğlu. (2005) Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients. Mycopathologia 159:4, pages 515-520.
Crossref
Frank C. Odds. 2005. Antibiotic Policies. Antibiotic Policies 311 330 .
Z. C. Karahan, H. Güriz, H. Ağırbaşlı, N. Balaban, J. S. Göçmen, D. Aysev & N. Akar. (2004) Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness . Mycoses 47:11-12, pages 465-469.
Crossref
Marc J. Struelens, Olivier Denis & Hector Rodriguez-Villalobos. (2004) Microbiology of nosocomial infections: progress and challenges. Microbes and Infection 6:11, pages 1043-1048.
Crossref
Sunit C. Singhi, Thimmapuram C. S. Reddy & Arunloke Chakrabarti. (2004) Candidemia in a pediatric intensive care unit. Pediatric Critical Care Medicine 5:4, pages 369-374.
Crossref
D. Swinne, M. Watelle, M. Van der Flaes & N. Nolard. (2004) In vitro activities of voriconazole (UK‐109, 496), fluconazole, itraconazole and amphotericin B against 132 non‐ albicans bloodstream yeast isolates (CANARI study) . Mycoses 47:5-6, pages 177-183.
Crossref
Peter G. Pappas, John H. Rex, Jack D. Sobel, Scott G. Filler, William E. Dismukes, Thomas J. Walsh & John E. Edwards. (2004) Guidelines for Treatment of Candidiasis. Clinical Infectious Diseases 38:2, pages 161-189.
Crossref
Janice (Wes) M. Y. Brown. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation 683 700 .
Sandra M. Swoboda, William G. Merz & Pamela A. Lipsetta. (2003) Candidemia: The Impact of Antifungal Prophylaxis in a Surgical Intensive Care Unit. Surgical Infections 4:4, pages 345-354.
Crossref
Roderick J Hay. (2003) Antifungal drugs used for systemic mycoses. Dermatologic Clinics 21:3, pages 577-587.
Crossref
M. A. Pfaller, S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis & D. J. Diekema. (2003) Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location . Journal of Clinical Microbiology 41:5, pages 2176-2179.
Crossref
C. A. Mullen, H. Abd. El-Baki, H. Samir, J. J. Tarrand & K. V. Rolston. (2003) Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Supportive Care in Cancer 11:5, pages 321-325.
Crossref
D.P. Kontoyiannis, E. Mantadakis & G. Samonis. (2003) Systemic mycoses in the immunocompromised host: an update in antifungal therapy. Journal of Hospital Infection 53:4, pages 243-258.
Crossref
Johannes Müller, Annemarie Polak, Reinhard Kappe, Dagmar Rimek, Michael Seibold & Kathrin TintelnotAnnemarie Polak. 2003. Antifungal Agents. Antifungal Agents 59 190 .
Helen L. Leather & John R. Wingard. (2002) Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?. Current Opinion in Infectious Diseases 15:4, pages 369-375.
Crossref
Dominique Sanglard & Frank C Odds. (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. The Lancet Infectious Diseases 2:2, pages 73-85.
Crossref
R. Khatib, Kathleen M. Riederer, J. Ramanathan & J. BaranJrJr. (2001) Faecal fungal flora in healthy volunteers and inpatients. Mycoses 44:5, pages 151-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.